Carlo Tanzi | Vice President, Investor Relations & Corporate Communications |
Eric Shaff | President & Chief Executive Officer |
Kevin Horgan | Chief Medical Officer |
Chris Shibutani | Cowen and Company |
Good day, ladies and gentlemen. And welcome to Second Quarter 2019 Seres Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference may be recorded.